Xtant Medical Holdings (XTNT) Shares Outstanding (Weighted Average) (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $139.5 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $139.5 million, up 4.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $139.5 million (up 4.39% YoY), and the FY2025 annual result was $139.5 million, up 4.39% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $139.5 million in Q4 2025 per XTNT's latest filing, from $139.7 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $139.7 million in Q3 2025 and troughed at $81.2 million in Q1 2021.
• A 5-year average of $112.2 million and a median of $114.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Weighted Average) surged 556.9% in 2021, then advanced 0.63% in 2022.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $85.5 million in 2021, then gained by 10.1% to $94.1 million in 2022, then gained by 26.58% to $119.1 million in 2023, then increased by 12.24% to $133.7 million in 2024, then increased by 4.39% to $139.5 million in 2025.
• Business Quant data shows XTNT's Shares Outstanding (Weighted Average) at $139.5 million in Q4 2025, $139.7 million in Q3 2025, and $139.2 million in Q2 2025.